ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

ClinicalTrials.gov ID: NCT02664558

Public ClinicalTrials.gov record NCT02664558. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 3:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)

Study identification

NCT ID
NCT02664558
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eiger BioPharmaceuticals
Industry
Enrollment
61 participants

Conditions and interventions

Interventions

  • placebo Other
  • ubenimex Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2016
Primary completion
Oct 31, 2017
Completion
Dec 31, 2017
Last update posted
Mar 5, 2023

2016 – 2018

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
25
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
California Heart Center Foundation, An Affiliate of Cedars-Sinai Heart Institute, Cedars-Sinai Medical Care Foundation Beverly Hills California 90211
UCSD Medical Center La Jolla California 92103
Stanford University Medical Center Stanford California 94305
University of Colorado Denver Aurora Colorado 80045
University of Florida Gainesville Florida 32610
Cleveland Clinic, Florida Weston Florida 33331
Kentuckiana Pulmonary Associates Louisville Kentucky 40202
Chest Medicine Associates South Portland Maine 04106
Johns Hopkins University, Pulmonary and Critical Care Medicine Baltimore Maryland 21205
Tufts Medical Center Boston Massachusetts 02111
Brigham and Women's Hospital Boston Massachusetts 02115
Boston University School of Medicine Boston Massachusetts 02118
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic College of Medicine Rochester Minnesota 55905
Washington University St Louis Missouri 63130
Weill Cornell Medicine New York New York 10065
The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
Duke University Medical Center Durham North Carolina 27710
Cleveland Clinic Respiratory Institute Cleveland Ohio 44195
University of Pennsylvania Philadelphia Pennsylvania 19104
Allegheny General Hospital Pittsburgh Pennsylvania 15212
University of Pennsylvania Medical Center Pittsburgh Pennsylvania 15213
Alpert Medical School of Brown University Rhode Island Hospital Providence Rhode Island 02903
Vanderbilt University Medical Center Nashville Tennessee 37232
UT Southwestern Medical Center Dallas Texas 75390
Houston Methodist Hospital Houston Texas 77030
University Texas Health Science Center San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02664558, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2023 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02664558 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →